Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them. Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive trans-catheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel’s or duct’s natural function.

There has been an increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients. The elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease, and improve the patient’s condition quickly through efficient and safer interventional products are fuelling the stents global market.

Due to the increasing prevalence of various kinds of stenotic diseases and cerebral aneurysm across the globe, there has been an increasing demand for highly efficient, minimally invasive therapeutic products from the value centric patient population. The other growth factors also include the trend of coronary stent price slashing and increasing competitiveness of the domestic players in some of the major APAC countries, emergence of technologically advanced stent products, persistently escalating geriatric population and the feasibility of even drug eluting stents (DES) in them and the numerous acquisitions and distribution agreements among the stent companies, developing healthcare infrastructural facilities and increasing demand for better healthcare services in the emerging markets.

The stents market is segmented by product, material, application, end-users and geography. Based on the product, the stents global market is segmented into bare metal stents, drug eluting stents (DES), bioresorbable stents and other stents consisting of covered stents and the non-drug eluting polymeric stents.

Based on the materials used, the stents global market is segmented into metal alloy based stents and polymer based stents. The metal alloy based stents is further categorized into cobalt-chrome alloy stents, nitinol or nickel-titanium alloy stents, platinum-chromium alloy stents, stainless steel stents and other metallic biomaterial stents like those made up of magnesium, iron and others. The polymer based stents includes stents made up of durable or biostable polymers and biodegradable polymers.Based on the application, stents global market is broadly classified as vascular and non-vascular stents. Among these, the vascular stents segment accounted for the largest revenue in 2020 and is expected to grow at a mid-single digit CAGR from 2020 to 2027 due to the persistently elevating prevalence of vascular stenotic conditions and cerebral aneurysm across the globe that is in need of various rapid, efficient, technologically advanced and minimally traumatizing therapeutic interventions like stenting.

Based on the end-users, the stents global market is divided into Hospitals; Ambulatory surgery centers (ASCs) and others consisting of Freestanding or mobile Catheterization Labs and Research Institutes. Based on the region, the stents global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Turkey, Rest of Latin America and Middle East & Africa). 

The exclusive market research report aims to provide a comprehensive study of the global market for stents, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyse their positions in the current marketplace, and make informed business decisions regarding stent devices.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares. The report also discusses technological trends and new product developments. Also, the scope of this report does not include endovascular graft/stent grafts indicated for aortic and other types of aneurysm treatment and for use in the treatment of free perforations or ruptures.

The leading global players of the market include Abbott Laboratories, B. Braun Melsungen AG, BD, Biotronik SE, Boston Scientific Corp., Cook Medical LLC, Medtronic plc. and Terumo Corp.